29 June 2022 · Four licensed ranibizumab biosimilars are available: Byooviz, Ongavia, Rimmyrah and Ximluci. Learn about the licensed indications and supporting evidence
16 June 2022 · Topical chloramphenicol can be used with caution and monitoring. Systemic chloramphenicol is not recommended. Advice applies to full term and healthy infants.
13 June 2022 · Guidance to help you ensure your patients with Parkinson’s Disease are able to get the most from their medicines if they develop swallowing difficulties
28 April 2022 · Hormone Replacement Therapy availability varies currently. Check for available products and keep up-to-date. Supply content is maintained regularly by DHSC.
31 March 2022 · There is some evidence on the effect of bariatric surgery (gastric bypass) on specific medicines which may inform prescribing decisions for those patients.
1 March 2022 · Gabapentin or pregabalin can be taken during breastfeeding and with infant monitoring. Recommendations apply to full term and healthy infants only.
27 January 2022 · Guidance on continuing or initiating commonly used antihistamines whilst breastfeeding. Recommendations apply to full term and healthy infants only.
20 January 2022 · Levothyroxine is the standard of care for treating hypothyroidism. Desiccated or natural thyroid extracts (DTE) are not routinely recommended.
2 November 2021 · Warfarin is the preferred choice during breastfeeding; rivaroxaban or dabigatran may also be used. Recommendations apply to full term and healthy infants.
26 October 2021 · High sodium content can make some medicines unsuitable for patients on a salt-restricted diet. Alternative products exist for a range of conditions.